Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129028) titled 'A study of dual immunotherapy combined with earplug-based noise reduction in recurrent or metastatic cervical cancer after progression on immunotherapy' on July 29.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fujian Cancer Hospital
Condition:
Recurrent or metastatic cervical cancer progressing after immunotherapy
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-08-01
Target Sample Size: Dual immunotherapy combined with earplug noise reduction intervention group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/s...